For the Inventor, By the Inventor

Enter assignee name

Cologne, Germany

Universität Zu Koln

USPTO Granted Patents = 28

% Expired Patents = 14.3

EPO Patents = 37

Forward Citations = 75

Loading Chart...

Loading Chart...

90 inventors (with patents filed for the assignee):

Ronald Kühne (4 out of 6 patents)

Hans-Günther Schmalz (4 out of 4 patents)

Matthias Müller (3 out of 3 patents)

4. Ralf Helmut Hetzer (3 out of 3 patents)

5. Dirk Blunk (3 out of 3 patents)

6. Albrecht Berkessel (2 out of 3 patents)

7. Cedric Reuter (2 out of 2 patents)

8. Robert Opitz (2 out of 2 patents)

9. Matthias Barone (2 out of 2 patents)

10. Hartmut Oschkinat (2 out of 5 patents)

11. Bernd Neumaier (2 out of 2 patents)

12. Boris Zlatopolskiy (2 out of 2 patents)

13. Raphael Richarz (2 out of 2 patents)

14. Angela Sager-Wiedmann (2 out of 2 patents)

15. Kai Wirz (2 out of 2 patents)

Core Competencies:

Immune Diseases

HIV Antibodies

Porous Electrode

Spermatozoa Fertility

Degenerative Diseases

Neoplastic Treatments

Cancer Biomarkers

Organic Light Emitting Diodes

Neurodegenerative Diseases

Fire-Extinguishing Foam

Stem Cell Elimination

28 patents: Sort by Forward Citations

1. 12678447 - COMBINATIONS OF RIPK1- AND IKK-INHIBITORS FOR THE PREVENTION OR TREATMENT OF IMMUNE DISEASES (2026-07-14),

2. 12643940 - BROADLY NEUTRALIZING ANTIBODIES AGAINST HIV (2026-06-02),

3. 12571951 - Interference filter and use of a stacked arrangement of layer structures as interference filter (2026-03-10),

4. 12537200 - Porous electrode and method for its preparation (2026-01-27),

5. 12195466 - Polyproline mimetics of proline-derived module-15 (2025-01-14),

6. 11774441 - Method for determining the fertility of spermatozoa comprising detection of vimentin variant 3 (2023-10-03),

7. 11609231 - Detection of autoantibodies for diagnosing degenerative diseases of the skeletal system (2023-03-21),

8. 11585815 - Method for diagnosis of a benign renal oncocytoma by means of VIM3 (2023-02-21),

9. 11542234 - 2-alkoxy-6-[18F]fluoronicotinoyl substituted lys-c(O)-glu derivatives as efficient probes for imaging of PSMA expressing tissues (2023-01-03),

10. 11299453 - Compounds for use in the elimination of pluripotent stem cells (2022-04-12),

11. 11085014 - Method of culturingspecies for manufacturing of astaxanthin (2021-08-10),

12. 10793509 - Compounds useful in the treatment of neoplastic diseases (2020-10-06),

13. 10344053 - Inhibitors for inhibiting tumor metastasis (2019-07-09),

14. 10307627 - Carbosilane containing fire-extinguishing foam (2019-06-04),

15. 10208354 - NRG1 fusion genes in cancer (2019-02-19),

Company Overview

Universität zu Köln is a prominent research university located in Cologne, Germany, known for its comprehensive academic programs and interdisciplinary research initiatives. The institution specializes in a wide range of fields, including humanities, social sciences, natural sciences, and medicine. It fosters innovation and collaboration, contributing significantly to advancements in various domains such as environmental science, economics, and health research. The university's strategic location enhances its engagement with both local and international academic communities.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

28 Patents

#24 in Cologne

#1,696 in Germany

#23,285 in the World

Cologne, Germany

Universität Zu Koln

Forward Citations = 75

90 inventors:

Ronald Kühne (4 out of 6 patents)

Hans-Günther Schmalz (4 out of 4 patents)

Matthias Müller (3 out of 3 patents)

4. Ralf Helmut Hetzer (3 out of 3 patents)

5. Dirk Blunk (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Universität Zu Koln. Retrieved from https://idiyas.com/company/universitat-zu-koln

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…